Citations

Clear

249 citation(s) found for "St-Denis, L".

Faculty Opinions recommendation of Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer.
Heppell, Jacques, Bouchard, Philippe

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | August 21, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.4390961.4221060 Get It

Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder
Malta, Chiara Di , Fryer, John Denis , Settembre, Carmine , Ballabio, Andrea

Mayo Clinic

Proceedings of the National Academy of Sciences | July 24, 2012 | Volume: 109 | Issue: 35 | Pages: No page available

10.1073/pnas.1209577109 | PMID 22826245 Get It

The role of astrocytes in neurodegenerative processes is increasingly appreciated. Here we investigated the contribution of astrocytes to neurodegeneration in multiple sulfatase deficiency (MSD), a severe lysosomal storage disorder caused by mutations in the sulfatase modifying factor 1 ( SUMF1 ) gene. Using Cre/Lox mouse models, we found that astrocyte-specific deletion of Sumf1 in vivo induced severe lysosomal storage and autophagy dysfunction with consequential cytoplasmic accumulation of autophagic substrates. Lysosomal storage in astrocytes was sufficient to induce degeneration of cortical neurons in vivo. Furthermore, in an ex vivo coculture assay, we observed that Sumf1 −/− astrocytes failed to support the survival and function of wild-type cortical neurons, suggesting a non-cell autonomous mechanism for neurodegeneration. Compared with the astrocyte-specific deletion of Sumf1 , the concomitant removal of Sumf1 in both neurons and glia in vivo induced a widespread neuronal loss and robust neuroinflammation. Finally, behavioral analysis of mice with astrocyte-specific deletion of Sumf1 compared with mice with Sumf1 deletion in both astrocytes and neurons allowed us to link a subset of neurological manifestations of MSD to astrocyte dysfunction. This study indicates that astrocytes are integral components of the neuropathology in MSD and that modulation of astrocyte function may impact disease course.
O1‐09‐01: CTNNA3, CAPRIN2 and SPG20 are significantly associated with Alzheimer's disease in preliminary analyses of a genome‐wide association study in African‐Americans
Reitz, Christiane , Hall, Kathleen, Evans, Denis A., Ertekin‐Taner, Nilüfer , Fallin, Danielle, Pericak‐Vance, Margaret A. , Haines, Jonathan L. , Mayeux, Richard , Schellenberg, Gerard D. , Manly, Jennifer J. , Bennett, David A. , Buxbaum, Joseph D. , Kamboh, M. Ilyas , Foroud, Tatiana , Goate, Alison , Farrer, Lindsay A.

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_3 | Pages: No page available

10.1016/j.jalz.2012.05.251 Get It

Influence of Muscle Afferents on Cutaneous and Muscle Vessels in the Dog
Clément, Denis, Shepherd, John T.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 35 | Issue: 2 | Pages: 177-183

10.1161/01.res.35.2.177 Get It

In 13 anesthetized dogs with their vagi cut and their carotid sinuses kept at constant pressure, the gracilis artery, cranial tibial artery, and lateral saphenous vein of the left hind limb were isolated and perfused at constant flow. In the right hind limb, muscle afferents were stimulated by electrodes in the thigh muscles. At 5 Hz, aortic blood pressure decreased 45 ± 8 mm Hg; perfusion pressure decreased in the gracilis muscle and the paw (26 ± 6 mm Hg and 26 ± 5 mm Hg, respectively) and increased in the saphenous vein (13 ± 3 mm Hg). These effects were not prevented by paralysis of the stimulated muscles, beta-receptor blockade, or administration of atropine or antihistaminic drugs. At 40 Hz, aortic blood pressure increased 29 ± 8 mm Hg; perfusion pressure increased in the gracilis muscle and the paw (33 ± 5 mm Hg and 33 ± 3 mm Hg, respectively) and decreased in the saphenous vein (20 ± 2 mm Hg). These effects were prevented or reversed by paralysis of the stimulated muscles. Similar effects were obtained by central stimulation of the femoral nerve. Left sympathectomy or alpha-receptor blockade abolished the responses in the isolated vascular beds. Thus, muscle contraction is necessary only to activate the muscle afferents which cause constriction of resistance vessels in muscle and paw and dilation of cutaneous veins.
Role of Muscular Contraction in the Reflex Vascular Responses to Stimulation of Muscle Afferents in the Dog
Clément, Denis, Pelletier, C, Shepherd, John T.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 33 | Issue: 4 | Pages: 386-392

10.1161/01.res.33.4.386 | PMID 4741940 Get It

The effect of stimulation of somatic afferents from muscle was investigated in 24 anesthetized dogs. The carotid sinuses were isolated and kept at constant pressure, the vagi were cut, and the left iliac artery was isolated and perfused at constant flow. Muscle afferents were stimulated by either inserting electrodes into the muscles of the right thigh or stimulating the central end of the right femoral nerve. Muscle stimulation at 5 Hz decreased perfusion pressure in the iliac artery 76 ± 6 mm Hg (mean ± SE ); the decrease was not prevented by paralysis of the stimulated muscles, administration of atropine or antihistamines, or -receptor blockade. Muscle stimulation at 40 Hz increased perfusion pressure in the iliac artery 28 ± 3 mm Hg. This increase was prevented or changed to a depressor response by muscle paralysis. Similar effects were obtained with femoral nerve stimulation. Both depressor and pressor responses persisted after the leg had been skinned and the muscles had been separated from their tendons, but they were abolished by left sympathectomy. Thus, skeletal muscle contraction is necessary for activation of the muscle afferents which cause reflex vasoconstriction but not for activation of those which cause reflex vasodilatation.
Role of Vagal Afferents In the Control of Renal Sympathetic Nerve Activity in the Rabbit
Clément, Denis, Pelletier, C, Shepherd, John T.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 31 | Issue: 6 | Pages: 824-830

10.1161/01.res.31.6.824 | PMID 4641779 Get It

Comparison of Afferent Activity of Canine Aortic and Sinus Nerves
Pelletier, C, Clément, Denis, Shepherd, John T.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 31 | Issue: 4 | Pages: 557-568

10.1161/01.res.31.4.557 | PMID 5075375 Get It

Pressure-dependent changes in afferent activity in the aortic and the sinus nerves were studied in 17 anesthetized dogs that were artificially ventilated with oxygen. Systemic arterial blood pressure was varied either continuously or in steps over the range of mean aortic blood pressure from 220 to 50 mm Hg with a pressurized reservoir connected to the abdominal aorta. Multifiber preparations from 20 aortic and 8 sinus nerves were used, and stimulusresponse curves were defined by measuring the mean impulse frequency at the various levels of pressure. Heart rate and pulse pressure were similar during recordings from both nerves. The two curves were S-shaped, with that for the aortic nerve being to the right of that for the sinus nerve. The change in activity was approximately linear from 200 to 120 mm Hg (mean aortic blood pressure) in the aortic nerve and from 180 to 80 mm Hg in the sinus nerve; there was no significant change in impulse frequency below mean blood pressures of 100 and 70 mm Hg, respectively. The threshold systolic blood pressure was 95 ± 3 (SE) mm Hg for the aortic receptors and 62 ± 4 mm Hg for the carotid sinus receptors. Thus, in the dog, the aortic baroreceptors are involved mainly in the control of high blood pressure, whereas at lower pressures the major control occurs through the carotid sinus baroreflex.
Operationalizing diagnostic criteria for Alzheimer's disease and other age‐related cognitive impairment—Part 2
Seshadri, Sudha , Beiser, Alexa , Au, Rhoda , Wolf, Philip A. , Evans, Denis A., Petersen, Ronald C. , Rocca, Walter A. , Kawas, Claudia H. , Corrada, María M. , Plassman, Brenda L. , Langa, Kenneth M. , Chui, Helena C., Wilson, Robert S. , Wilson, R. J. , Knopman, David S. , Seshadri, Sudha , Au, Rhoda

Mayo Clinic

Alzheimer's & Dementia | January 20, 2011 | Volume: 7 | Issue: 1 | Pages: 35-52

10.1016/j.jalz.2010.12.002 | PMID 21255742 Get It

This article focuses on the effects of operational differences in case ascertainment on estimates of prevalence and incidence of cognitive impairment and/or dementia of the Alzheimer type. Experience and insights are discussed by investigators from the Framingham Heart Study, the East Boston Senior Health Project, the Chicago Health and Aging Project, the Mayo Clinic Study of Aging, the Baltimore Longitudinal Study of Aging, and the Aging, Demographics, and Memory Study. There is a general consensus that the single most important factor determining prevalence estimates of Alzheimer's disease (AD) is the severity of cognitive impairment used as a threshold to define cases. Studies that require a level of cognitive impairment in which persons are unable to provide self‐care will have much lower estimates than the studies aimed at identifying persons in the earliest stages of AD. There are limited autopsy data from the aforementioned epidemiological studies to address accuracy in the diagnosis of etiological subtype, namely the specification of AD alone or in combination with other types of pathology. However, other community‐based cohort studies show that many persons with mild cognitive impairment and also some persons without dementia or mild cognitive impairment meet pathological criteria for AD, thereby suggesting that the number of persons who would benefit from an effective secondary prevention intervention is probably higher than the published prevalence estimates. Improved accuracy in the clinical diagnosis of AD is anticipated with the addition of molecular and structural biomarkers in the next generation of epidemiological studies.
Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States
Rocca, Walter A. , Petersen, Ronald C. , Hebert, Liesi E., Evans, Denis A. , Hall, Kathleen, Gao, Sujuan , Unverzagt, Frederick W. , Langa, Kenneth M. , Larson, Eric B. , White, Lon R. , Knopman, David S.

Mayo Clinic

Alzheimer's & Dementia | January 20, 2011 | Volume: 7 | Issue: 1 | Pages: 80-93

10.1016/j.jalz.2010.11.002 | PMID 21255746 Get It

Declines in heart disease and stroke mortality rates are conventionally attributed to reductions in cigarette smoking, recognition and treatment of hypertension and diabetes, effective medications to improve serum lipid levels and to reduce clot formation, and general lifestyle improvements. Recent evidence implicates these and other cerebrovascular factors in the development of a substantial proportion of dementia cases. Analyses were undertaken to determine whether corresponding declines in age‐specific prevalence and incidence rates for dementia and cognitive impairment have occurred in recent years. Data spanning 1 or 2 decades were examined from community‐based epidemiological studies in Minnesota, Illinois, and Indiana, and from the Health and Retirement Study, which is a national survey. Although some decline was observed in the Minnesota cohort, no statistically significant trends were apparent in the community studies. A significant reduction in cognitive impairment measured by neuropsychological testing was identified in the national survey. Cautious optimism appears justified.
Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat
Schulz, Tim J. , Huang, Tian Lian , Tran, Thien T. , Zhang, Hongbin , Townsend, Kristy L. , Shadrach, Jennifer L. , Cerletti, Massimiliano , McDougall, Lindsay, Giorgadze, Nino, Tchkonia, Tamar , Schrier, Denis J., Falb, Dean, Kirkland, James L. , Wagers, Amy J. , Tseng, Yu‐Hua , Tchkonia, T

Mayo Clinic

Proceedings of the National Academy of Sciences | December 20, 2010 | Volume: 108 | Issue: 1 | Pages: 143-148

10.1073/pnas.1010929108 | PMID 21173238 Get It

Brown fat is specialized for energy expenditure and has therefore been proposed to function as a defense against obesity. Despite recent advances in delineating the transcriptional regulation of brown adipocyte differentiation, cellular lineage specification and developmental cues specifying brown-fat cell fate remain poorly understood. In this study, we identify and isolate a subpopulation of adipogenic progenitors (Sca-1 + /CD45 − /Mac1 − ; referred to as Sca-1 + progenitor cells, ScaPCs) residing in murine brown fat, white fat, and skeletal muscle. ScaPCs derived from different tissues possess unique molecular expression signatures and adipogenic capacities. Importantly, although the ScaPCs from interscapular brown adipose tissue (BAT) are constitutively committed brown-fat progenitors, Sca-1 + cells from skeletal muscle and subcutaneous white fat are highly inducible to differentiate into brown-like adipocytes upon stimulation with bone morphogenetic protein 7 (BMP7). Consistent with these findings, human preadipocytes isolated from subcutaneous white fat also exhibit the greatest inducible capacity to become brown adipocytes compared with cells isolated from mesenteric or omental white fat. When muscle-resident ScaPCs are re-engrafted into skeletal muscle of syngeneic mice, BMP7-treated ScaPCs efficiently develop into adipose tissue with brown fat-specific characteristics. Importantly, ScaPCs from obesity-resistant mice exhibit markedly higher thermogenic capacity compared with cells isolated from obesity-prone mice. These data establish the molecular characteristics of tissue-resident adipose progenitors and demonstrate a dynamic interplay between these progenitors and inductive signals that act in concert to specify brown adipocyte development.